Recent Advances in Inflammation & Allergy Drug Discovery

Recent Advances in Inflammation & Allergy Drug Discovery

Editor-in-Chief

ISSN (Print): 2772-2708
ISSN (Online): 2772-2716

Back Subscribe
Review Article

Multifaceted Role of Tiliroside in Inflammatory Pathways: Mechanisms and Prospects

Author(s): Gurjeet Kaur, Jasleen Kaur, Jayant Goyal, Lavish Vaid, Thakur Gurjeet Singh, Randhir Singh and Sushma Devi*

Volume 19, Issue 3, 2025

Published on: 23 October, 2024

Page: [316 - 327] Pages: 12

DOI: 10.2174/0127722708316269241015160515

Price: $65

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Tiliroside, a natural polyphenolic compound found in several plant sources, has garnered attention for its potential to mitigate inflammation and its associated diseases. The current review explores the multifaceted functions of Tiliroside in inflammation-related diseases, delving into the underlying mechanisms and prospects for therapeutic applications. Tiliroside exerts its anti-inflammatory effects through a variety of mechanisms, such as the inhibition of inflammatory mediators’ cytokines and chemokines, as well as the suppression of nuclear factor-kappa B (NF-κB) signaling pathways. Additionally, it demonstrates potent antioxidant properties, which further contribute to its anti-inflammatory activity by reducing oxidative stress. In preclinical studies, Tiliroside has shown promising results in ameliorating inflammation in conditions like rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis. Furthermore, Tiliroside's ability to modulate immune responses and stimulate tissue regeneration contributes to its potential as a multimodal agent in treating inflammation-associated disorders. In conclusion, Tiliroside emerges as a promising natural compound with a multifaceted role in inflammation-related diseases with understanding the underlying mechanisms of its therapeutic prospects may pave the way for novel treatments.

Keywords: Tiliroside, inflammation, NF-κB, MAPK, TNF-α, TLR, Nfr2.

Graphical Abstract

[1]
Maleki SJ, Crespo JF, Cabanillas B. Anti-inflammatory effects of flavonoids. Food Chem 2019; 299: 125124.
[http://dx.doi.org/10.1016/j.foodchem.2019.125124] [PMID: 31288163]
[2]
Alharthy K, Balaha M, Devi S, et al. Ameliorative effects of isoeugenol and eugenol against impaired nerve function and inflammatory and oxidative mediators in diabetic neuropathic rats. Biomedicines 2023; 11(4): 1203.
[http://dx.doi.org/10.3390/biomedicines11041203] [PMID: 37189822]
[3]
Rahman MM, Rahaman MS, Islam MR, et al. Role of phenolic compounds in human disease: current knowledge and future prospects. Molecules 2021; 27(1): 233.
[http://dx.doi.org/10.3390/molecules27010233] [PMID: 35011465]
[4]
Ginwala R, Bhavsar R, Chigbu DGI, Jain P, Khan ZK. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants 2019; 8(2): 35.
[http://dx.doi.org/10.3390/antiox8020035] [PMID: 30764536]
[5]
Alsawaf S, Alnuaimi F, Afzal S, et al. Plant flavonoids on oxidative stress-mediated kidney inflammation. Biology 2022; 11(12): 1717.
[http://dx.doi.org/10.3390/biology11121717] [PMID: 36552226]
[6]
Foudah AI, Devi S, Alam A, Salkini MA, Ross SA. Anticholinergic effect of resveratrol with vitamin E on scopolamine-induced Alzheimer’s disease in rats: Mechanistic approach to prevent inflammation. Front Pharmacol 2023; 14: 1115721.
[http://dx.doi.org/10.3389/fphar.2023.1115721] [PMID: 36817151]
[7]
Rajendran P, Rengarajan T, Nandakumar N, Palaniswami R, Nishigaki Y, Nishigaki I. Kaempferol, a potential cytostatic and cure for inflammatory disorders. Eur J Med Chem 2014; 86: 103-12.
[http://dx.doi.org/10.1016/j.ejmech.2014.08.011] [PMID: 25147152]
[8]
Tan J, Yadav MK, Devi S, Kumar M. Neuroprotective effects of arbutin against oxygen and glucose deprivation-induced oxidative stress and neuroinflammation in rat cortical neurons. Acta Pharm 2022; 72(1): 123-34.
[http://dx.doi.org/10.2478/acph-2022-0002] [PMID: 36651531]
[9]
Ullah A, Munir S, Badshah SL, et al. Important flavonoids and their role as a therapeutic agent. Molecules 2020; 25(22): 5243.
[http://dx.doi.org/10.3390/molecules25225243] [PMID: 33187049]
[10]
Sindhu R, Arora S. Anti-inflammatory potential of different extracts isolated from the roots of Ficus lacor buch. Hum and Murraya koenigii L. spreng. Arch Biol Sci 2014; 66(3): 1261-70.
[http://dx.doi.org/10.2298/ABS1403261S]
[11]
Behl T, Upadhyay T, Singh S, et al. Polyphenols targeting MAPK mediated oxidative stress and inflammation in rheumatoid arthritis. Molecules 2021; 26(21): 6570.
[http://dx.doi.org/10.3390/molecules26216570] [PMID: 34770980]
[12]
Aodah AH, Devi S, Alkholifi FK, Yusufoglu HS, Foudah AI, Alam A. Effects of taraxerol on oxidative and inflammatory mediators in isoproterenol-induced cardiotoxicity in an animal model. Molecules 2023; 28(10): 4089.
[http://dx.doi.org/10.3390/molecules28104089] [PMID: 37241830]
[13]
Jin X, Song S, Wang J, Zhang Q, Qiu F, Zhao F. Tiliroside, the major component of Agrimonia pilosa Ledeb ethanol extract, inhibits MAPK/JNK/p38-mediated inflammation in lipopolysaccharide-activated RAW 264.7 macrophages. Exp Ther Med 2016; 12(1): 499-505.
[http://dx.doi.org/10.3892/etm.2016.3305] [PMID: 27347085]
[14]
Goto T, Teraminami A, Lee JY, et al. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese–diabetic mice. J Nutr Biochem 2012; 23(7): 768-76.
[http://dx.doi.org/10.1016/j.jnutbio.2011.04.001] [PMID: 21889885]
[15]
Matsuda H, Ninomiya K, Shimoda H, Yoshikawa M. Hepatoprotective principles from the flowers of Tilia argentea (Linden): structure requirements of tiliroside and mechanisms of action. Bioorg Med Chem 2002; 10(3): 707-12.
[http://dx.doi.org/10.1016/S0968-0896(01)00321-2] [PMID: 11814859]
[16]
Nowak R. Separation and quantification of tiliroside from plant extracts by SPE/RP-HPLC. Pharm Biol 2003; 41(8): 627-30.
[http://dx.doi.org/10.1080/13880200390502559]
[17]
Grochowski DM, Locatelli M, Granica S, Cacciagrano F, Tomczyk M. A review on the dietary flavonoid tiliroside. Compr Rev Food Sci Food Saf 2018; 17(5): 1395-421.
[http://dx.doi.org/10.1111/1541-4337.12389] [PMID: 33350157]
[18]
Luhata LP, Luhata WG. TILIROSIDE: Biosynthesis, bioactivity and structure activity relationship (SAR) - A review. J Phytopharmacol 2017; 6(6): 343-8.
[http://dx.doi.org/10.31254/phyto.2017.6607]
[19]
Devi S, Rangra NK, Rawat R, et al. Anti-atherogenic effect of Nepitrin-7-O-glucoside: A flavonoid isolated from Nepeta hindostana via acting on PPAR – α receptor. Steroids 2021; 165: 108770.
[http://dx.doi.org/10.1016/j.steroids.2020.108770] [PMID: 33227319]
[20]
Diuzheva A, Carradori S, Andruch V, et al. Use of innovative (Micro) extraction techniques to characterise Harpagophytum procumbens root and its commercial food supplements. Phytochem Anal 2018; 29(3): 233-41.
[http://dx.doi.org/10.1002/pca.2737] [PMID: 29143440]
[21]
Turfus S, Delgoda R, Picking D, Gurley B. Pharmacokinetics. Pharmacognosy. Academic Press 2017.
[http://dx.doi.org/10.1016/B978-0-12-802104-0.00025-1]
[22]
Zan T, Piao L, Wei Y, Gu Y, Liu B, Jiang D. Simultaneous determination and pharmacokinetic study of three flavonoid glycosides in rat plasma by LC–MS/MS after oral administration of Rubus chingii Hu extract. Biomed Chromatogr 2018; 32(3): e4106.
[http://dx.doi.org/10.1002/bmc.4106] [PMID: 28976589]
[23]
Luo Z, Morgan MRA, Day AJ. Transport of trans-tiliroside (kaempferol-3-β-D-(6″-p-coumaroyl-glucopyranoside) and related flavonoids across Caco-2 cells, as a model of absorption and metabolism in the small intestine. Xenobiotica 2015; 45(8): 722-30.
[http://dx.doi.org/10.3109/00498254.2015.1007492] [PMID: 25761590]
[24]
Sousa AP, Fernandes DA, Ferreira MDL, et al. 2023. Analysis of the toxicological and pharmacokinetic profile of Kaempferol-3-O-β-D-(6”-E-p-coumaryl) glucopyranoside - Tiliroside: in silico, in vitro and ex vivo assay. Brazilian Journal of Biology 83.
[25]
Yin X, Wang M, Xia Z. In vitro evaluation of intestinal absorption of tiliroside from Edgeworthia gardneri (Wall.) Meisn. Xenobiotica 2021; 51(6): 728-36.
[http://dx.doi.org/10.1080/00498254.2021.1904304] [PMID: 33874851]
[26]
Zhang W, Liu D, Zhou E, Wang W, Wang H, Li Q. Hepatoprotective effect of tiliroside and characterization of its metabolites in human hepatocytes by ultra-high performance liquid chromatography-high resolution mass spectrometry. J Funct Foods 2023; 107: 105675.
[http://dx.doi.org/10.1016/j.jff.2023.105675]
[27]
Zinatizadeh MR, Schock B, Chalbatani GM, Zarandi PK, Jalali SA, Miri SR. The Nuclear Factor κ B (NF-kB) signaling in cancer development and immune diseases. Genes Dis 2021; 8(3): 287-97.
[http://dx.doi.org/10.1016/j.gendis.2020.06.005] [PMID: 33997176]
[28]
Yadav S, Srivastava S, Singh G. Platelet‐rich plasma exhibits anti‐inflammatory effect and attenuates cardiomyocyte damage by reducing NF‐κB and enhancing VEGF expression in isoproterenol induced cardiotoxicity model. Environ Toxicol 2022; 37(4): 936-53.
[http://dx.doi.org/10.1002/tox.23456] [PMID: 35014750]
[29]
An J, Chen B, Kang X, et al. Neuroprotective effects of natural compounds on LPS-induced inflammatory responses in microglia. Am J Transl Res 2020; 12(6): 2353-78.
[PMID: 32655777]
[30]
Liu Y, Yang X, Liu Y, et al. NRF2 signalling pathway: New insights and progress in the field of wound healing. J Cell Mol Med 2021; 25(13): 5857-68.
[http://dx.doi.org/10.1111/jcmm.16597] [PMID: 34145735]
[31]
Sehnert B, Burkhardt H, Dübel S, Voll RE. Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases. Cells 2020; 9(7): 1627.
[http://dx.doi.org/10.3390/cells9071627] [PMID: 32640727]
[32]
Velagapudi R, Aderogba M, Olajide OA. Tiliroside, a dietary glycosidic flavonoid, inhibits TRAF-6/NF-κB/p38-mediated neuroinflammation in activated BV2 microglia. Biochim Biophys Acta, Gen Subj 2014; 1840(12): 3311-9.
[http://dx.doi.org/10.1016/j.bbagen.2014.08.008] [PMID: 25152356]
[33]
Radziejewska I, Supruniuk K, Tomczyk M, et al. p-Coumaric acid, Kaempferol, Astragalin and Tiliroside Influence the Expression of Glycoforms in AGS Gastric Cancer Cells. Int J Mol Sci 2022; 23(15): 8602.
[http://dx.doi.org/10.3390/ijms23158602] [PMID: 35955735]
[34]
Lacy P, Stow JL. Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood 2011; 118(1): 9-18.
[http://dx.doi.org/10.1182/blood-2010-08-265892] [PMID: 21562044]
[35]
Foudah AI, Devi S, Alqarni MH, et al. Quercetin attenuates nitroglycerin-induced migraine headaches by inhibiting oxidative stress and inflammatory mediators. Nutrients 2022; 14(22): 4871.
[http://dx.doi.org/10.3390/nu14224871] [PMID: 36432556]
[36]
Hu X. li J, Fu M, Zhao X, Wang W. The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 2021; 6(1): 402.
[http://dx.doi.org/10.1038/s41392-021-00791-1] [PMID: 34824210]
[37]
Kaur G, Devi S, Sharma A, Sood P. Pharmacological insights and role of bufalin (bufadienolides) in inflammation modulation: a narrative review. Inflammopharmacology 2024; 32(5): 3057-77.
[http://dx.doi.org/10.1007/s10787-024-01517-9] [PMID: 39012431]
[38]
Hu Q, Bian Q, Rong D, et al. JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. Front Bioeng Biotechnol 2023; 11: 1110765.
[http://dx.doi.org/10.3389/fbioe.2023.1110765] [PMID: 36911202]
[39]
Yin Q, Wang L, Yu H, Chen D, Zhu W, Sun C. Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway. Front Pharmacol 2021; 12: 716672.
[http://dx.doi.org/10.3389/fphar.2021.716672] [PMID: 34539403]
[40]
Sala A, Recio MC, Schinella GR, et al. Assessment of the anti-inflammatory activity and free radical scavenger activity of tiliroside. Eur J Pharmacol 2003; 461(1): 53-61.
[http://dx.doi.org/10.1016/S0014-2999(02)02953-9] [PMID: 12568916]
[41]
Fahmideh H, Shapourian H, Moltafeti R, et al. The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment. Oxid Med Cell Longev 2022; 2022: 1-17.
[http://dx.doi.org/10.1155/2022/7838583] [PMID: 36193062]
[42]
Mishra A, Mishra PS, Bandopadhyay R, et al. Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders. Molecules 2021; 26(21): 6456.
[http://dx.doi.org/10.3390/molecules26216456] [PMID: 34770864]
[43]
Wang D, Ali F, Liu H, et al. Quercetin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and activation of JAK2/STAT3 pathway: A target based networking pharmacology approach. Front Pharmacol 2022; 13: 1002363.
[http://dx.doi.org/10.3389/fphar.2022.1002363] [PMID: 36324691]
[44]
Moens U, Kostenko S, Sveinbjørnsson B. The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation. Genes (Basel) 2013; 4(2): 101-33.
[http://dx.doi.org/10.3390/genes4020101] [PMID: 24705157]
[45]
Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 2011; 75(1): 50-83.
[http://dx.doi.org/10.1128/MMBR.00031-10] [PMID: 21372320]
[46]
Ayroldi E, Cannarile L, Migliorati G, Nocentini G, Delfino DV, Riccardi C. Mechanisms of the anti‐inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways. FASEB J 2012; 26(12): 4805-20.
[http://dx.doi.org/10.1096/fj.12-216382] [PMID: 22954589]
[47]
Merecz-Sadowska A, Sitarek P, Śliwiński T, Zajdel R. Anti-Inflammatory Activity of Extracts and Pure Compounds Derived from Plants via Modulation of Signaling Pathways, Especially PI3K/AKT in Macrophages. Int J Mol Sci 2020; 21(24): 9605.
[http://dx.doi.org/10.3390/ijms21249605] [PMID: 33339446]
[48]
Velagapudi R, Olajide OA, Aderogba MA. Tiliroside produced anti-neuroinflammatory effects through interference with NF-κB And MAPK signalling in LPS+ IFN-γ stimulated BV-2 microglia 2014. Available from: http://www.pA2online.org/abstracts/Vol11Issue3abst093P.pdf (accessed on 2-10-2024)
[49]
Olajide OA, Sarker SD. Alzheimer’s disease: natural products as inhibitors of neuroinflammation. Inflammopharmacology 2020; 28(6): 1439-55.
[http://dx.doi.org/10.1007/s10787-020-00751-1] [PMID: 32930914]
[50]
Foudah AI, Alqarni MH, Devi S, et al. Analgesic action of catechin on chronic constriction injury–induced neuropathic pain in Sprague–Dawley rats. Front Pharmacol 2022; 13: 895079.
[http://dx.doi.org/10.3389/fphar.2022.895079] [PMID: 36034867]
[51]
Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr 2010; 20(2): 87-103.
[http://dx.doi.org/10.1615/CritRevEukarGeneExpr.v20.i2.10] [PMID: 21133840]
[52]
Ruiz A, Palacios Y, Garcia I, Chavez-Galan L. Transmembrane TNF and Its Receptors TNFR1 and TNFR2 in Mycobacterial Infections. Int J Mol Sci 2021; 22(11): 5461.
[http://dx.doi.org/10.3390/ijms22115461] [PMID: 34067256]
[53]
Behl T, Mehta K, Sehgal A, et al. Exploring the role of polyphenols in rheumatoid arthritis. Crit Rev Food Sci Nutr 2022; 62(19): 5372-93.
[http://dx.doi.org/10.1080/10408398.2021.1924613] [PMID: 33998910]
[54]
Jang D, Lee AH, Shin HY, et al. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. Int J Mol Sci 2021; 22(5): 2719.
[http://dx.doi.org/10.3390/ijms22052719] [PMID: 33800290]
[55]
Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 2009; 1(4): a000034-4.
[http://dx.doi.org/10.1101/cshperspect.a000034] [PMID: 20066092]
[56]
Sameer AS, Nissar S. Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility. BioMed Res Int 2021; 2021: 1-14.
[http://dx.doi.org/10.1155/2021/1157023] [PMID: 34552981]
[57]
Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009; 22(2): 240-73.
[http://dx.doi.org/10.1128/CMR.00046-08] [PMID: 19366914]
[58]
Roh JS, Sohn DH. Damage-Associated Molecular Patterns in Inflammatory Diseases. Immune Netw 2018; 18(4): e27.
[http://dx.doi.org/10.4110/in.2018.18.e27] [PMID: 30181915]
[59]
Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010; 2010: 1-21.
[http://dx.doi.org/10.1155/2010/672395] [PMID: 20706656]
[60]
Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol 2014; 5: 461.
[http://dx.doi.org/10.3389/fimmu.2014.00461] [PMID: 25309543]
[61]
Pouremamali F, Pouremamali A, Dadashpour M, Soozangar N, Jeddi F. An update of Nrf2 activators and inhibitors in cancer prevention/promotion. Cell Commun Signal 2022; 20(1): 100.
[http://dx.doi.org/10.1186/s12964-022-00906-3] [PMID: 35773670]
[62]
Kryszczuk M, Kowalczuk O. Significance of NRF2 in physiological and pathological conditions an comprehensive review. Arch Biochem Biophys 2022; 730: 109417.
[http://dx.doi.org/10.1016/j.abb.2022.109417] [PMID: 36202215]
[63]
Hu C, Zhao JF, Wang YM, Wu X, Ye L. Tiliroside induces ferroptosis to repress the development of triple-negative breast cancer cells. Tissue Cell 2023; 83: 102116.
[http://dx.doi.org/10.1016/j.tice.2023.102116] [PMID: 37301139]
[64]
Han R, Yang H, Lu L, Lin L. Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis. Sci Rep 2021; 11(1): 8626.
[http://dx.doi.org/10.1038/s41598-021-88133-7] [PMID: 33883691]
[65]
Dai M, Wikantyasning E, Wahyuni A, Kusumawati I, Saifudin A, Suhendi A. Antiproliferative properties of tiliroside from Guazuma ulmifolia lamk on T47D and MCF7 cancer cell lines. Natl J Physiol Pharm Pharmacol 2016; 6(6): 627.
[http://dx.doi.org/10.5455/njppp.2016.6.0617727072016]
[66]
Fernandes DA, Oliveira LHG, Rique HL, Souza MFV, Nunes FC. Insights on the larvicidal mechanism of action of fractions and compounds from aerial parts of Helicteres velutina K. Schum against Aedes aegypti L. Molecules 2020; 25(13): 3015.
[http://dx.doi.org/10.3390/molecules25133015] [PMID: 32630318]
[67]
Tomczyk M, Drozdowska D, Bielawska A, Bielawski K, Gudej J. Human DNA topoisomerase inhibitors from Potentilla argentea and their cytotoxic effect against MCF-7. Pharmazie 2008; 63(5): 389-93.
[PMID: 18557426]
[68]
Yuan Z, Luan G, Wang Z, et al. Flavonoids from Potentilla parvifoliaFisch. and their neuroprotective effects in human neuroblastoma SH ‐ SY 5Y Cells in vitro. Chem Biodivers 2017; 14(6): e1600487.
[http://dx.doi.org/10.1002/cbdv.201600487] [PMID: 28294523]
[69]
Ninomiya K, Matsuda H, Kubo M, Morikawa T, Nishida N, Yoshikawa M. Potent anti-obese principle from Rosa canina: Structural requirements and mode of action of trans-tiliroside. Bioorg Med Chem Lett 2007; 17(11): 3059-64.
[http://dx.doi.org/10.1016/j.bmcl.2007.03.051] [PMID: 17400451]
[70]
Qiao W, Zhao C, Qin N, Zhai HY, Duan HQ. Identification of trans-tiliroside as active principle with anti-hyperglycemic, anti-hyperlipidemic and antioxidant effects from Potentilla chinesis. J Ethnopharmacol 2011; 135(2): 515-21.
[http://dx.doi.org/10.1016/j.jep.2011.03.062] [PMID: 21463674]
[71]
Han N, Gu Y, Ye C, Cao Y, Liu Z, Yin J. Antithrombotic activity of fractions and components obtained from raspberry leaves (Rubus chingii). Food Chem 2012; 132(1): 181-5.
[http://dx.doi.org/10.1016/j.foodchem.2011.10.051] [PMID: 26434278]
[72]
Silva G, Pereira A, Rezende B, et al. Mechanism of the antihypertensive and vasorelaxant effects of the flavonoid tiliroside in resistance arteries. Planta Med 2013; 79(12): 1003-8.
[http://dx.doi.org/10.1055/s-0032-1328765] [PMID: 23877918]
[73]
Li X, Tian Y, Wang T, et al. Role of the p-coumaroyl moiety in the antioxidant and cytoprotective effects of flavonoid glycosides: Comparison of astragalin and tiliroside. Molecules 2017; 22(7): 1165.
[http://dx.doi.org/10.3390/molecules22071165] [PMID: 28704976]
[74]
Li K, Xiao Y, Wang Z, et al. Tiliroside is a new potential therapeutic drug for osteoporosis in mice. J Cell Physiol 2019; 234(9): 16263-74.
[http://dx.doi.org/10.1002/jcp.28289] [PMID: 30815860]
[75]
Shimoda H, Tanaka J, Zaiki K, Nakaoji K. Tiliroside, a constituent of strawberry seeds, slightly enhances hyaluronan production via hyaluronan synthase 2 expression in mouse skin and human fibroblasts. Int J Biomed Sci 2019; 15(1): 24-31.
[http://dx.doi.org/10.59566/IJBS.2019.15024]
[76]
Gao D, Fu QF, Wang LJ, et al. Molecularly imprinted polymers for the selective extraction of tiliroside from the flowers of Edgeworthia gardneri (wall.) Meisn. J Sep Sci 2017; 40(12): 2629-37.
[http://dx.doi.org/10.1002/jssc.201700240] [PMID: 28453223]
[77]
Ayinde BA, Owolabi JO, Uti IS, Ogbeta PC, Choudhary MI. Isolation of the antidiarrhoeal tiliroside and its derivative from Waltheria indica leaf extract. Niger J Nat Prod Med 2021; 25(1): 86-92.
[http://dx.doi.org/10.4314/njnpm.v25i1.10]
[78]
Shaw P, Xiao M, Zhang T, et al. Tiliroside, a polymerase inhibitor from Hibiscus mutabilis L., exhibits anti-influenza activity in vitro and in vivo. SSRN 2022.
[http://dx.doi.org/10.2139/ssrn.4229801]
[79]
Wang P, Hu M, Wang L, et al. Chemical constituents and coagulation effects of the flowers of Rosa chinensis Jacq. J Fut Foods 2023; 3(2): 155-62.
[http://dx.doi.org/10.1016/j.jfutfo.2022.12.006]
[80]
Alkholifi FK, Devi S, Aldawsari MF, et al. Effects of Tiliroside and Lisuride co-treatment on the PI3K/Akt signal pathway: Modulating neuroinflammation and apoptosis in Parkinson’s Disease. Biomedicines 2023; 11(10): 2735.
[http://dx.doi.org/10.3390/biomedicines11102735] [PMID: 37893109]
[81]
Kozai Y, Matsuura Y. Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: A randomized, double-blind, placebo-controlled clinical trial. Diabetes Metab Syndr Obes 2015; 8: 147-56.

Rights & Permissions Print Cite